DR. RENE BERNARDS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Filing Date Source Excerpt
2022-08-26 Dr. Rene Bernards is a leader in the field of molecular carcinogenesis, working at the Netherlands Cancer Institute in Amsterdam.
2023-10-10 Dr. Rene Bernards is a leader in the field of molecular carcinogenesis, working at the Netherlands Cancer Institute in Amsterdam.

Data sourced from SEC filings. Last updated: 2026-03-05